AU550607B2 - Allylamines as monoamine oxidase inhibitors; intermediate allyl alcohols - Google Patents
Allylamines as monoamine oxidase inhibitors; intermediate allyl alcoholsInfo
- Publication number
- AU550607B2 AU550607B2 AU84238/82A AU8423882A AU550607B2 AU 550607 B2 AU550607 B2 AU 550607B2 AU 84238/82 A AU84238/82 A AU 84238/82A AU 8423882 A AU8423882 A AU 8423882A AU 550607 B2 AU550607 B2 AU 550607B2
- Authority
- AU
- Australia
- Prior art keywords
- sub
- integer
- hydrogen
- formula
- phenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000002899 monoamine oxidase inhibitor Substances 0.000 title abstract 2
- 229940123685 Monoamine oxidase inhibitor Drugs 0.000 title 1
- 150000004808 allyl alcohols Chemical class 0.000 title 1
- -1 3,4-methylendioxyphenyl Chemical group 0.000 abstract 6
- 239000001257 hydrogen Substances 0.000 abstract 4
- 229910052739 hydrogen Inorganic materials 0.000 abstract 4
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 4
- 150000002431 hydrogen Chemical class 0.000 abstract 3
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 2
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 2
- 229910052794 bromium Inorganic materials 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- 229910052731 fluorine Inorganic materials 0.000 abstract 2
- 239000011737 fluorine Substances 0.000 abstract 2
- 125000001637 1-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C(*)=C([H])C([H])=C([H])C2=C1[H] 0.000 abstract 1
- 125000002941 2-furyl group Chemical group O1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000001622 2-naphthyl group Chemical group [H]C1=C([H])C([H])=C2C([H])=C(*)C([H])=C([H])C2=C1[H] 0.000 abstract 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 abstract 1
- 125000000389 2-pyrrolyl group Chemical group [H]N1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 abstract 1
- 125000003682 3-furyl group Chemical group O1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- 125000001397 3-pyrrolyl group Chemical group [H]N1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- 125000001541 3-thienyl group Chemical group S1C([H])=C([*])C([H])=C1[H] 0.000 abstract 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 229940082992 antihypertensives mao inhibitors Drugs 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 abstract 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 abstract 1
- 229910052801 chlorine Inorganic materials 0.000 abstract 1
- 239000000460 chlorine Substances 0.000 abstract 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 abstract 1
- QWPPOHNGKGFGJK-UHFFFAOYSA-N hypochlorous acid Chemical compound ClO QWPPOHNGKGFGJK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 231100000252 nontoxic Toxicity 0.000 abstract 1
- 230000003000 nontoxic effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 239000011593 sulfur Substances 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C209/00—Preparation of compounds containing amino groups bound to a carbon skeleton
- C07C209/62—Preparation of compounds containing amino groups bound to a carbon skeleton by cleaving carbon-to-nitrogen, sulfur-to-nitrogen, or phosphorus-to-nitrogen bonds, e.g. hydrolysis of amides, N-dealkylation of amines or quaternary ammonium compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/44—Iso-indoles; Hydrogenated iso-indoles
- C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
- C07C29/132—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group
- C07C29/136—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH
- C07C29/147—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring by reduction of an oxygen containing functional group of >C=O containing groups, e.g. —COOH of carboxylic acids or derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
- C07C33/48—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
- C07C33/483—Monocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C33/00—Unsaturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
- C07C33/40—Halogenated unsaturated alcohols
- C07C33/46—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts
- C07C33/48—Halogenated unsaturated alcohols containing only six-membered aromatic rings as cyclic parts with unsaturation outside the aromatic rings
- C07C33/486—Polycyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/225—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing halogen
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/23—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/09—Geometrical isomers
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
- Indole Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Purification Treatments By Anaerobic Or Anaerobic And Aerobic Bacteria Or Animals (AREA)
- Treatment Of Sludge (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
- Pretreatment Of Seeds And Plants (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US268555 | 1981-06-01 | ||
| US06/268,555 US4454158A (en) | 1981-06-01 | 1981-06-01 | Allyl amine MAO inhibitors |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU51805/86A Division AU576281B2 (en) | 1981-06-01 | 1986-01-02 | 2-aryl 3 halo allyl alcohols |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU8423882A AU8423882A (en) | 1983-02-03 |
| AU550607B2 true AU550607B2 (en) | 1986-03-27 |
Family
ID=23023513
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU84238/82A Ceased AU550607B2 (en) | 1981-06-01 | 1982-05-27 | Allylamines as monoamine oxidase inhibitors; intermediate allyl alcohols |
| AU51805/86A Ceased AU576281B2 (en) | 1981-06-01 | 1986-01-02 | 2-aryl 3 halo allyl alcohols |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU51805/86A Ceased AU576281B2 (en) | 1981-06-01 | 1986-01-02 | 2-aryl 3 halo allyl alcohols |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4454158A (OSRAM) |
| EP (1) | EP0067105B1 (OSRAM) |
| JP (1) | JPS5823649A (OSRAM) |
| KR (1) | KR890002756B1 (OSRAM) |
| AT (1) | ATE29875T1 (OSRAM) |
| AU (2) | AU550607B2 (OSRAM) |
| CA (2) | CA1187500A (OSRAM) |
| DE (1) | DE3277371D1 (OSRAM) |
| DK (1) | DK244282A (OSRAM) |
| ES (4) | ES512699A0 (OSRAM) |
| GB (2) | GB2100255B (OSRAM) |
| GR (1) | GR78033B (OSRAM) |
| IE (1) | IE53456B1 (OSRAM) |
| IL (2) | IL65808A (OSRAM) |
| MX (1) | MX9202950A (OSRAM) |
| NO (1) | NO152837C (OSRAM) |
| NZ (1) | NZ200644A (OSRAM) |
| ZA (1) | ZA823633B (OSRAM) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4699928A (en) * | 1984-07-13 | 1987-10-13 | Merrell Dow Pharmaceuticals Inc. | Fluoroallylamine derivatives |
| NZ214697A (en) * | 1984-12-31 | 1988-10-28 | Merrell Dow Pharma | B-methylene-2- and 3-furanethanamine and pharmaceutical compositions |
| US4703058A (en) * | 1984-12-31 | 1987-10-27 | Merrell Dow Pharmaceuticals Inc. | β-methylene furanethanamines and use as anti-hypertensive agents |
| NZ214698A (en) * | 1984-12-31 | 1988-08-30 | Merrell Dow Pharma | Thiophene derivatives and pharmaceutical compositions containing such |
| US4650907A (en) * | 1985-12-05 | 1987-03-17 | Merrell Dow Pharmaceuticals Inc. | Nonaromatic fluoroallylamine MAO inhibitors |
| ES2033233T3 (es) * | 1985-12-05 | 1993-03-16 | Merrell Dow Pharmaceuticals Inc. | Un procedimiento para preparar una fluoralilamina. |
| US4822812A (en) * | 1987-05-21 | 1989-04-18 | Merrell Dow Pharmaceuticals Inc. | β-(Fluoromethylene)-5-hydroxytryptophan and derivatives and their use as prodrugs for MAO inhibition |
| ZA884183B (en) * | 1987-06-16 | 1989-02-22 | Merrell Dow Pharma | (e)-2-(p-fluorophenethyl)-3-fluoroallylamine |
| FI890827A7 (fi) * | 1988-02-25 | 1989-08-26 | Merrell Dow Pharma | Lysyloxidas-inhibitorer. |
| US5059714A (en) * | 1988-02-25 | 1991-10-22 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US4965288A (en) * | 1988-02-25 | 1990-10-23 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US5252608A (en) * | 1988-02-25 | 1993-10-12 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US4943593A (en) * | 1988-02-25 | 1990-07-24 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US5182297A (en) * | 1988-02-25 | 1993-01-26 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US5120764A (en) * | 1988-11-01 | 1992-06-09 | Merrell Dow Pharmaceuticals Inc. | Inhibitors of lysyl oxidase |
| US4981868A (en) * | 1989-07-25 | 1991-01-01 | Merrell Dow Pharmaceutical | Pharmaceutically active 3-heteroaryl-2-fluoro-1-olefins |
| SI0814789T2 (sl) * | 1995-03-02 | 2008-04-30 | Scherer Technologies Inc R P | Farmacevtske zmesi, ki obsegajo inhibitorje monoamin oksidaze b |
| EP2004166A2 (en) * | 2006-03-31 | 2008-12-24 | La Jolla Pharmaceutical Company | Inhibitors of semicarbazide-sensitive amine oxidase (ssao) and vap-1 mediated adhesion useful for treatment and prevention of diseases |
| WO2008006761A1 (de) * | 2006-07-13 | 2008-01-17 | Basf Se | Fungizide azolopyrimidine, verfahren zu ihrer herstellung und ihre verwendung zur bekämpfung von schadpilzen sowie sie enthaltende mittel |
| WO2009055002A1 (en) * | 2007-10-24 | 2009-04-30 | La Jolla Pharmaceutical Company | Combined inhibitors of cyclooxygenase and semicarbazide-sensitive amine oxidase (ssao) (vascular adhesion protein, vap-1) |
| CA2706465A1 (en) | 2007-11-21 | 2009-05-28 | Pharmaxis Ltd. | Haloallylamine inhibitors of ssao/vap-1 and uses therefor |
| PT2844637T (pt) | 2012-05-02 | 2018-04-17 | Boehringer Ingelheim Int | Inibidores de 3-haloalilamina substituídos de ssao e as suas utilizações |
| WO2015087094A1 (en) * | 2013-12-10 | 2015-06-18 | Semmelweis Egyetem | New arylalkenylpropargylamine derivatives exhibiting neuroprotective action for the treatment of neurodegenerative diseases |
| AU2019315330B2 (en) | 2018-08-03 | 2024-10-17 | Syntara Limited | Haloallylamine sulfone derivative inhibitors of lysyl oxidases and uses thereof |
| US12233056B2 (en) | 2022-04-06 | 2025-02-25 | Syntara Limited | Lysyl oxidase inhibitors for treating myeloid malignancies |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2343038A1 (de) * | 1973-08-25 | 1975-03-06 | Hoechst Ag | 2,3-diaryl-3-halogenallylamine und verfahren zu ihrer herstellung |
| SE7809127L (sv) * | 1978-08-30 | 1980-03-01 | Claesson Alf | Allenaminer |
-
1981
- 1981-06-01 US US06/268,555 patent/US4454158A/en not_active Expired - Lifetime
-
1982
- 1982-05-17 NZ NZ200644A patent/NZ200644A/en unknown
- 1982-05-17 IL IL65808A patent/IL65808A/xx not_active IP Right Cessation
- 1982-05-21 GB GB8214854A patent/GB2100255B/en not_active Expired
- 1982-05-25 ZA ZA823633A patent/ZA823633B/xx unknown
- 1982-05-25 IE IE1246/82A patent/IE53456B1/en not_active IP Right Cessation
- 1982-05-27 EP EP82400991A patent/EP0067105B1/en not_active Expired
- 1982-05-27 AT AT82400991T patent/ATE29875T1/de active
- 1982-05-27 DE DE8282400991T patent/DE3277371D1/de not_active Expired
- 1982-05-27 AU AU84238/82A patent/AU550607B2/en not_active Ceased
- 1982-05-28 CA CA000403943A patent/CA1187500A/en not_active Expired
- 1982-05-28 DK DK244282A patent/DK244282A/da not_active Application Discontinuation
- 1982-05-28 NO NO821799A patent/NO152837C/no not_active IP Right Cessation
- 1982-05-31 ES ES512699A patent/ES512699A0/es active Granted
- 1982-05-31 GR GR68306A patent/GR78033B/el unknown
- 1982-05-31 KR KR8202435A patent/KR890002756B1/ko not_active Expired
- 1982-06-01 JP JP57092250A patent/JPS5823649A/ja active Granted
-
1983
- 1983-07-05 ES ES523874A patent/ES8503638A1/es not_active Expired
- 1983-07-05 ES ES523873A patent/ES523873A0/es active Granted
- 1983-07-05 ES ES523875A patent/ES8503639A1/es not_active Expired
-
1984
- 1984-11-15 GB GB08428858A patent/GB2152039B/en not_active Expired
-
1985
- 1985-03-13 CA CA000476463A patent/CA1204759A/en not_active Expired
- 1985-07-17 IL IL75829A patent/IL75829A0/xx unknown
-
1986
- 1986-01-02 AU AU51805/86A patent/AU576281B2/en not_active Ceased
-
1992
- 1992-06-17 MX MX9202950A patent/MX9202950A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US4454158B1 (OSRAM) | ||
| NO812311L (no) | Bronchospasmolytisk virksomme forbindelser og fremgangsmaate for deres fremstilling | |
| KR900007406A (ko) | 리실 옥시마제의 억제제 | |
| DK1089998T3 (da) | Epothilon-derivater samt deres syntese og anvendelse | |
| PH17786A (en) | New methyl substituted 4-methoxy-pyridine-n-oxides to be used as intermediate in the preparation of the new intermediate | |
| DE69711923D1 (de) | ARYL- ODER HETEROARYL-SUBSTITUIERTE 3,4-DIHYDROANTHRACENE SOWIE ARYL- ODER HETEROARYL-SUBSTITUIERTE BENZO[1,2g]-CHROM-3-EN-, BENZO[1,2g]-THIOCHROM-3-EN- UND BENZO[1,2g]-1,2-DIHYDROCHINOLIN-DERIVATE MIT RETINOID ANTAGONISTISCHER ODER INVERS ANTAGONISTISCHER AKTIVITÄT | |
| AU3797189A (en) | Piperidine derivatives | |
| RU94045271A (ru) | Применение 2-фенил-3-ароилбензотиофенов для ингибирования синдрома тернера | |
| MXPA02005366A (es) | Copolimeros de bloques asi como procedimiento para la elaboracion y su empleo. | |
| NO20001887L (no) | Preparat til behandling av trevirke | |
| FI934680A0 (fi) | Arylmorfolin, framstaellning och anvaending | |
| ES8105054A1 (es) | Procedimiento para la preparacion de mezclas de aclaradores opticos | |
| SU940629A3 (ru) | Способ регулировани роста растений | |
| KR890012641A (ko) | 리실 옥시다제의 억제제 | |
| HUP0303422A2 (hu) | Bőrt nedvesítő készítmény | |
| AU6924094A (en) | PsoralenTM* derivatives, their preparation and use | |
| GB1380765A (en) | Phthalimidine derivatives | |
| GB1476906A (en) | Aromatic ethers and thioethers | |
| PE8898A1 (es) | Procedimiento de obtencion de derivados 1,3-propanodiamina y compuestos intermedios |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK14 | Patent ceased section 143(a) (annual fees not paid) or expired |